CTXR (STOCKS)
Citius Pharmaceuticals Inc. Common
$0.806600
+0.001600 (+0.20%)
Prev close: $0.805000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Leonard L. Mazur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.34M
- Employees
- 23
- P/E (TTM)
- -0.28
- P/B (TTM)
- 0.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q4)
|
$-0.72 | $-0.50 | -0.2236 | -45.04% |
|
Jun 2025 (Q3)
|
$-0.80 | $-0.60 | -0.1982 | -32.93% |
|
Mar 2025 (Q2)
|
$-1.27 | $-0.39 | -0.8790 | -224.81% |
|
Dec 2024 (Q1)
|
$-1.30 | $-0.59 | -0.7118 | -121.01% |
Financial Statements
| Revenues | $3.94M |
| Nonoperating Income/Loss | -$290.75K |
| Operating Expenses | $40.66M |
| Research and Development | $8.63M |
| Other Operating Expenses | $32.03M |
| Operating Income/Loss | -$37.51M |
| Income/Loss From Continuing Operations After Tax | -$38.85M |
| Income/Loss From Continuing Operations Before Tax | -$37.80M |
| Income Tax Expense/Benefit | $1.06M |
| Income Tax Expense/Benefit, Deferred | $1.06M |
| Net Income/Loss | -$38.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$2.97M |
| Net Income/Loss Attributable To Parent | -$36.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.56 |
| Diluted Earnings Per Share | -$2.56 |
| Basic Average Shares | 43,128,246 |
| Diluted Average Shares | 43,128,246 |
| Assets | $140.39M |
| Current Assets | $37.95M |
| Inventory | $22.64M |
| Prepaid Expenses | $3.54M |
| Other Current Assets | $11.77M |
| Noncurrent Assets | $102.45M |
| Liabilities | $46.92M |
| Current Liabilities | $38.21M |
| Accounts Payable | $11.02M |
| Wages | $3.09M |
| Other Current Liabilities | $24.09M |
| Noncurrent Liabilities | $8.72M |
| Equity | $93.47M |
| Equity Attributable To Noncontrolling Interest | $13.51M |
| Equity Attributable To Parent | $79.96M |
| Liabilities And Equity | $140.39M |
| Net Cash Flow From Operating Activities | -$34.84M |
| Net Cash Flow From Operating Activities, Continuing | -$34.84M |
| Net Cash Flow From Investing Activities | -$12.30M |
| Net Cash Flow From Investing Activities, Continuing | -$12.30M |
| Net Cash Flow From Financing Activities | $51.61M |
| Net Cash Flow From Financing Activities, Continuing | $51.61M |
| Net Cash Flow | $4.47M |
| Net Cash Flow, Continuing | $4.47M |
| Comprehensive Income/Loss | -$38.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.85M |
| Other Comprehensive Income/Loss | $0.00 |